trial

Psychosis and Affective Research Domains and Intermediate Phenotypes

NCTId NCT02218853
as of 2026-07-01
at a glance
Phase — · Completed
Enrollment 113 (actual)
Primary completion 2017-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
113 (actual)
Study type
Observational
Allocation
Model
Masking
Start
2014-04
Primary completion
2017-06
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Sponsors

Investigators

1
Carol A. Tamminga, M.D.Principal Investigator

Sites

1 total
Dallas, United States

Facts & assertions

4 sourced
Enrollment
113
Phase
NA
Primary Completion Date
2017-06
Status
COMPLETED